Inventurus Knowledge Solutions Ltd

Inventurus Knowledge Solutions has approved the grant of 131,114 stock option to certain eligible employees under the IKS ESOP Plan on 16 June 2026.

Axis Bank Ltd, Alkyl Amines Chemicals Ltd, J B Chemicals & Pharmaceuticals Ltd, Uno Minda Ltd are among the other stocks to see a surge in volumes on BSE today, 14 May 2026.Inventurus Knowledge Solutions Ltd clocked volume of 1.9 lakh shares by 10:47 IST on BSE, a 14.87 times surge over two-week average daily volume of 12786 shares. The stock gained 0.73% to Rs.1,688.95. Volumes stood at 5835 shares in the last session.Axis Bank Ltd recorded volume of 65.1 lakh shares by 10:47 IST on BSE, a 11.98 times surge over two-week average daily volume of 5.43 lakh shares. The stock lost 1.14% to Rs.1,241.40. Volumes stood at 4.41 lakh shares in the last session.Alkyl Amines Chemicals Ltd witnessed volume of 1.15 lakh shares by 10:47 IST on BSE, a 11.89 times surge over two-week average daily volume of 9684 shares. The stock increased 12.52% to Rs.1,838.15. Volumes stood at 3539 shares in the last session.J B Chemicals & Pharmaceuticals Ltd witnessed volume of 1.56 lakh shares by 10:47 IST on BSE, a 9.35 times surge over two-week average daily volume of 16715 shares. The stock increased 0.77% to Rs.2,111.00. Volumes stood at 14362 shares in the last session.Uno Minda Ltd saw volume of 2.34 lakh shares by 10:47 IST on BSE, a 6.42 fold spurt over two-week average daily volume of 36380 shares. The stock dropped 1.31% to Rs.1,111.40. Volumes stood at 56905 shares in the last session.Powered by Capital Market - Live

Net profit of Inventurus Knowledge Solutions rose 39.36% to Rs 205.97 crore in the quarter ended March 2026 as against Rs 147.80 crore during the previous quarter ended March 2025. Sales rose 18.47% to Rs 857.65 crore in the quarter ended March 2026 as against Rs 723.96 crore during the previous quarter ended March 2025. For the full year,net profit rose 48.45% to Rs 721.55 crore in the year ended March 2026 as against Rs 486.06 crore during the previous year ended March 2025. Sales rose 19.89% to Rs 3193.79 crore in the year ended March 2026 as against Rs 2663.99 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales857.65723.96 18 3193.792663.99 20 OPM %34.3831.24 -33.8828.89 - PBDT287.01208.42 38 1029.07718.95 43 PBT252.96180.09 40 904.92606.28 49 NP205.97147.80 39 721.55486.06 48 Powered by Capital Market - Live

Inventurus Knowledge Solutions will hold a meeting of the Board of Directors of the Company on 13 May 2026.

TruBridge is a fully integrated clinical and financial partner for small and mid-small size hospitals in the USA, offering electronic medical records (EMR) solutions and revenue cycle management (RCM) services. This proposed strategic acquisition underscores a commitment to broaden access to high-quality care and support the clinicians and hospitals that serve communities across the United States. The combined company would bring together IKS Health's care enablement services and TruBridge's expertise in revenue cycle management and electronic health record solutions, particularly for rural and community hospitals. Its goal is to strengthen local healthcare systems and improve access to essential care closer to patients' homes while supporting both ambulatory and acute care. After the merger, the company will focus on improving workflows and operations by combining artificial intelligence with human oversight to address complex challenges. As it integrates more clinical and financial data, the platform is expected to become more efficient and effective, helping healthcare organizations maintain financial stability and focus on patient care. Overall, the organization will provide revenue cycle management, predictive analytics, and advanced EHR solutions to over 2,000 healthcare organizations and more than 150,000 clinicians to improve clinical, operational, and financial performance. Under the terms of the agreement, TruBridge shareholders will receive $26.25 in cash for each share of common stock. The acquisition has been approved by the Boards of Directors of IKS Health, IKS, and TruBridge, and is expected to close during the third calendar quarter of 2026, subject to the satisfaction of customary closing conditions. IKS will finance the acquisition primarily through the incurrence of new indebtedness, including a term loan underwritten by Citibank, JPMorganChase, and Deutsche Bank, which is subject to satisfaction of customary conditions (including approval of the shareholders of IKS Health). Inventurus Knowledge Solutions (IKS Health) is a leading technology enabled healthcare solutions provider, primarily serving the US healthcare market. It offers a comprehensive care enablement platform that supports healthcare enterprises across outpatient and inpatient care settings. The company's consolidated net profit jumped 41.37% to Rs 183.32 crore on 24.01% jump in revenue from operations to Rs 814.95 crore in Q3 FY26 over Q3 FY25.

Inventurus Knowledge Solutions, Inc. (IKS), the U.S. subsidiary of Inventurus Knowledge Solutions (IKS Health), announced it has entered into a definitive agreement to acquire TruBridge, Inc. (NASDAQ: TBRG) (TruBridge), a prominent provider of healthcare technology solutions for rural and community hospitals. This proposed strategic acquisition underscores a commitment to broaden access to high-quality care and support the clinicians and hospitals that serve communities across the United States. By bringing together IKS Health's comprehensive care enablement capabilities that serve a range of healthcare organizations with TruBridge's deep expertise in supporting rural and community hospitals through revenue cycle management and electronic health record (EHR) solutions, the combined healthcare technology company is expected to strengthen local healthcare systems, and enable patients to receive essential care closer to home while also enhancing care delivery across the ambulatory and acute care continuum. Post closing, the combined company will deliver continuous improvement and connected workflows to the core of rural healthcare and to medical groups overall, combining agentic artificial intelligence (AI) with human-in-the-loop expertise to proactively address complex operational challenges. As the platform incorporates a broader range of clinical and financial data, it is designed to become increasingly intelligent and efficient. This growing intelligence, reinforced by human insight, is anticipated to ensure community hospitals and medical groups have the financial resilience and advanced support needed to focus on the health of their patients.

Inventurus Knowledge Solutions has approved grant of 75,000 employee stock options under the IKS ESOP Plan on 20 February 2026. Powered by Capital Market - Live

Profit before tax (PBT) climbed 43.22% YoY to Rs 229.37 crore in Q3 FY26. EBITDA jumped 40% to Rs 281.6 crore in Q3 FY26, registering the growth of 40% compared with Rs 271.8 crore in Q3 FY25.EBITDA margin improved to 34.6% in Q3 FY26 as against 30.5% in Q3 FY25. Sachin K. Gupta, founder & Global CEO, IKS Health,said, 'Our strong Q3 performance, characterized by 24% revenue growth, validatesthat our Care Enablement Platform is the critical solution for a US healthcare market facing a perfect storm of cost, quality, and access pressures. As physician marginsface renewed compression from stagnant reimbursement rates, we are seeing this act as a powerful catalyst for increased outsourcing and platform adoption. We continue to deepen our value proposition by advancing our AI capabilities'specifically moving our Patient Engagement suite toward multi-agent orchestration'to drive cognitive reasoning and independent action. Our recent wins with partners like StrideCare and VitalMD demonstrate that provider enterprises are increasingly choosing our integrated platform to ensure their financial sustainability and clinical efficiency.' Nithya Balasubramanian, Group CFO, IKS Health said, 'Our Q3 FY2026 performance underscores our consistent ability to drive profitable growth and deliver significant value to our clients. We achieved a 24% year-on-year revenue increase and a 41% growth in Profit After Tax (PAT), fueled by continuous expansion across existing and new client relationships. Margin expansion is a direct result of our successful operating leverage, technology deployment and focused cost management. ' Inventurus Knowledge Solutions (IKS Health) is a leading technology enabled healthcare solutions provider, primarily serving the US healthcare market. It offers a comprehensive care enablement platform that supports healthcare enterprises across outpatient and inpatient care settings.Powered by Capital Market - Live

Net profit of Inventurus Knowledge Solutions rose 41.37% to Rs 183.33 crore in the quarter ended December 2025 as against Rs 129.68 crore during the previous quarter ended December 2024. Sales rose 24.01% to Rs 814.95 crore in the quarter ended December 2025 as against Rs 657.16 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales814.95657.16 24 OPM %34.2627.61 - PBDT261.42187.91 39 PBT229.37160.16 43 NP183.33129.68 41 Powered by Capital Market - Live

Inventurus Knowledge Solutions will hold a meeting of the Board of Directors of the Company on 4 February 2026.Powered by Capital Market - Live